Vectron Biosolutions AS is your expert on developing cost-effective microbial production processes for recombinant proteins

Do you need to cut manufacturing costs?

The manufacturing costs of many recombinant proteins can be significantly reduced through increasing titres and improving the solubility of the proteins, reducing the necessities of costly downstream processes. This is increasingly important in the competitive landscape of the biopharmaceutical industry, especially with the advent of biosimilars and biobetters, as well as for suppliers of industrial enzymes where the markets are smaller.

Vectron Biosolutions is your upstream expert on developing robust, cost-efficient production processes for recombinant proteins in E. coli and other bacteria. We have proprietary next-generation expression tools and decades of experience that is available to you through partnerships and licensing.

Latest news

  • In memoriam: Svein Valla

    September 18 | 2017

    Professor Svein Valla, founder of Vectron, passed away September 13.

    Read more
  • Vectron is sponsoring

    August 30 | 2017

    Vectron is the proud sponsor of the NTNU iGEM 2017 team.

    Read more
  • New review paper

    March 30 | 2017

    A brilliant review paper of the XylS/Pm system has recently been published.

    Read more
  • Vectron is hiring.

    March 14 | 2017

    Please visit our Career page for information on available positions.

Complete newslist


  • BioNetwork West 2017; Laguna Niguel, California

    Oct 23–25 | 2017
  • CPhl Worldwide; Frankfurt, Germany

    Oct 24–26 | 2017
  • BIO-Europe; Berlin, Germany

    Nov 06–08 | 2017
  • Conference on Genetic and Protein Engineering; Las Vegas, USA

    Nov 08–09 | 2017
  • PEGS Europe; Lisbon, Portugal

    Nov 13–17 | 2017
  • JP Morgan / Biotech Showcase; San Francisco, California

    Jan 08–10 | 2018
Meet us there!
More events